Equities

Xinjiang Bai Hua Cun Pharma Tech Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Xinjiang Bai Hua Cun Pharma Tech Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)9.13
  • Today's Change-0.14 / -1.51%
  • Shares traded8.22m
  • 1 Year change+33.09%
  • Beta0.8093
Data delayed at least 15 minutes, as of Feb 12 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Xinjiang Bai Hua Cun Pharma Tech Co Ltd is a China-based company principally engaged in pharmaceutical services. The Company's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The Company is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The Company is also engaged in leasing and property services. The Company mainly conducts business within the domestic market.

  • Revenue in CNY (TTM)393.73m
  • Net income in CNY50.20m
  • Incorporated1996
  • Employees731.00
  • Location
    Xinjiang Bai Hua Cun Pharma Tech Co LtdNo. 1 South Lane, Zhongshan RoadWULUMUQI 830002ChinaCHN
  • Phone+86 9 912356600
  • Fax+86 9 912356601
  • Websitehttp://www.xjbhc.net/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Xinjiang Bai Hua Cun Pharma Tech Co Ltd393.73m50.20m3.56bn731.0070.924.49--9.050.13070.13071.022.060.35031.941.88538,619.704.47-4.606.16-6.3851.8224.7512.75-16.331.81--0.00--4.468.04219.753.82-0.975--
Qingdao Vland Biotech INC1.39bn83.57m4.01bn1.57k48.122.26--2.880.3290.3295.507.010.45853.893.65--3.764.846.116.9444.1945.528.209.540.877--0.264832.3510.169.30-22.39-4.23-2.71-6.89
Hinova Pharmaceuticals Inc23.61m-144.57m4.50bn173.00--4.09--190.62-1.46-1.460.238411.120.01712.375.59136,467.70-10.45-26.09-11.68-29.7495.50---612.36-78,863.606.90--0.0883-----38.6732.18--139.77--
Shanghai Aladdin Biochemical Tech Co Ltd599.98m83.95m5.28bn652.0063.864.95--8.800.24850.24851.783.210.27850.42184.55920,216.305.047.816.908.6062.2160.6118.0924.951.539.150.354148.3332.4420.5515.079.1741.61--
Hangzhou Alltest Biotech Co Ltd881.63m294.76m5.48bn969.0018.561.40--6.223.723.7211.1249.210.20982.386.39909,839.107.0219.187.5721.6655.0057.7933.4738.828.34--0.009335.1414.8329.1367.5030.9971.01--
Bide Pharmatech Co Ltd1.27bn153.31m5.57bn738.0034.892.78--4.391.761.7614.4922.030.51670.88045.251,720,520.006.247.027.528.2943.3042.1612.0713.132.78--0.105548.730.929834.697.17--80.65--
Shouyao Holdings Co Ltd2.14m-206.73m5.80bn178.00--8.87--2,708.43-1.39-1.390.01444.400.00250.03660.262512,033.88-23.67-32.53-27.20-36.2595.7499.43-9,651.03-3,370.016.42--0.0044---24.61-19.34-14.21--49.71--
Jiangsu Yahong Meditech Co Ltd279.02m-362.17m6.92bn391.00--3.90--24.79-0.642-0.6420.49333.100.12511.164.19713,603.90-16.84-14.30-19.15-15.0172.2273.78-134.65-703.804.96--0.1545--1,365.55--4.09--50.48--
Data as of Feb 12 2026. Currency figures normalised to Xinjiang Bai Hua Cun Pharma Tech Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

0.84%Per cent of shares held by top holders
HolderShares% Held
CITIC-Prudential Fund Management Co., Ltd.as of 30 Jun 20252.62m0.70%
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025387.20k0.10%
Shanghai Guotai Junan Securities Assets Management Co., Ltd.as of 30 Jun 202557.50k0.02%
GF Fund Management Co., Ltd.as of 30 Jun 202553.60k0.01%
China Southern Asset Management Co., Ltd.as of 30 Jun 202524.30k0.01%
Bosera Asset Management Co., Ltd.as of 30 Jun 20256.60k0.00%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 20254.40k0.00%
Harvest Fund Management Co., Ltd.as of 30 Jun 20251.40k0.00%
Guotai Asset Management Co., Ltd.as of 30 Jun 20250.000.00%
Dimensional Fund Advisors LPas of 30 Jun 20250.000.00%
More ▼
Data from 30 Jun 2025 - 05 Feb 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.